Reducing the risk of fractures--the options narrow for cost-effective therapeutic alternatives.
Curtiss
Frederic R
FR
D000368:Aged; D015519:Bone Density; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D020249:Hormone Replacement Therapy; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy / Q000517:prevention & control*; D010349:Patient Compliance; D014481:United States; D014486:United States Food and Drug Administration; D016387:Women's Health
D004164:Diphosphonates